BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6739959)

  • 41. Effect of endotoxin shock on the clearance of lidocaine and indocyanine green in the perfused rat liver.
    McKindley DS; Chichester C; Raymond R
    Shock; 1999 Dec; 12(6):468-72. PubMed ID: 10588516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of antiorthostatic bed rest on hepatic blood flow in man.
    Putcha L; Cintron NM; Vanderploeg JM; Chen Y; Habis J; Adler J
    Aviat Space Environ Med; 1988 Apr; 59(4):306-8. PubMed ID: 3370038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
    Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
    J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
    Hashimoto M; Watanabe G
    Hepatogastroenterology; 2000; 47(36):1669-74. PubMed ID: 11149029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of H2 receptor blockers on renal function. An attempt to accurately measure glomerular filtration].
    Motyl W
    Ann Acad Med Stetin; 2004; 50(1):97-105. PubMed ID: 16871748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The handling of indocyanine green by the liver.
    Paumgartner G
    Schweiz Med Wochenschr; 1975; 105(17 Suppl):1-30. PubMed ID: 1135620
    [No Abstract]   [Full Text] [Related]  

  • 48. The influence of dye infusion rate and hepatic plasma flow on indocyanine green clearance.
    Krarup N; Larsen JA
    Scand J Clin Lab Invest; 1976 Mar; 36(2):183-8. PubMed ID: 1273495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of single-dose and short-term oral nifedipine on indocyanine green clearance as assessed by spectrophotometry and high performance liquid chromatography.
    Soons PA; Kroon JM; Breimer DD
    J Clin Pharmacol; 1990 Aug; 30(8):693-8. PubMed ID: 2401748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cimetidine and hepatic blood flow in polytrauma patients.
    Ivatury RR; Khan MB; Nallathambi M; Davis K; Stahl WM
    Crit Care Med; 1985 May; 13(5):436-7. PubMed ID: 3987323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of roxatidine acetate and cimetidine on hepatic drug clearance assessed by simultaneous administration of three model substrates.
    Tanaka E; Nakamura K
    Br J Clin Pharmacol; 1989 Aug; 28(2):171-4. PubMed ID: 2570603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of cimetidine on the pharmacokinetics of the new beta-blocker betaxolol.
    Rey E; Jammet P; d'Athis P; de Lauture D; Christoforov B; Weber S; Olive G
    Arzneimittelforschung; 1987 Aug; 37(8):953-6. PubMed ID: 2890358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism for reduced drug clearance in patients with cirrhosis.
    Pessayre D; Lebrec D; Descatoire V; Peignoux M; Benhamou JP
    Gastroenterology; 1978 Mar; 74(3):566-71. PubMed ID: 631487
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect on apparent liver blood flow of histamine-receptor blockers and inhibition of prostaglandin synthesis.
    Feely J; Wood AJ
    Clin Pharmacol Ther; 1983 Jan; 33(1):91-4. PubMed ID: 6129092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatic drug clearance: the effect of age using indocyanine green as a model compound.
    Wynne HA; Goudevenos J; Rawlins MD; James OF; Adams PC; Woodhouse KW
    Br J Clin Pharmacol; 1990 Oct; 30(4):634-7. PubMed ID: 2291878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of physical exercise on the pharmacokinetics of propranolol.
    Arends BG; Böhm RO; van Kemenade JE; Rahn KH; van Baak MA
    Eur J Clin Pharmacol; 1986; 31(3):375-7. PubMed ID: 3792439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cimetidine and ethanol].
    Papke J; Borgmann H; Dökert B; Bartels H; Krause D
    Z Gesamte Inn Med; 1989 Dec; 44(24):731-3. PubMed ID: 2629368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proceedings: The influence of chronic liver disease on the elimination of d-propranolol, anti-pyrine, and indocyanine green.
    Branch RA; James JA; Read AE
    Gut; 1974 Oct; 15(10):837-8. PubMed ID: 4434964
    [No Abstract]   [Full Text] [Related]  

  • 59. Kinetics of indocyanine green and blood flow through the isolated perfused liver.
    Hůlek P; Skaunic V; Martínková J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1987; 30(1):139-55. PubMed ID: 3481869
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
    Wood AJ; Vestal RE; Wilkinson GR; Branch RA; Shand DG
    Clin Pharmacol Ther; 1979 Jul; 26(1):16-20. PubMed ID: 445957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.